Jun Zhao Selected Research

Tyrosine Kinase Inhibitors

1/2023	Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer.
12/2022	Prevention of variceal rebleeding in cirrhotic patients with advanced hepatocellular carcinoma receiving molecularly targeted therapy: a randomized pilot study of transjugular intrahepatic portosystemic shunt versus endoscopic plus β-blocker.
4/2022	Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with EGFRm+ non-small-cell lung cancer.
1/2021	Predicting Tyrosine Kinase Inhibitor Treatment Response in Stage IV Lung Adenocarcinoma Patients With EGFR Mutation Using Model-Based Deep Transfer Learning.
1/2020	Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation.
1/2020	Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib.
9/2019	Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.
12/2018	Identifying epidermal growth factor receptor mutation status in patients with lung adenocarcinoma by three-dimensional convolutional neural networks.
11/2018	Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study.
10/2018	Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun Zhao Research Topics

Disease

401	Neoplasms (Cancer) 05/2024 - 08/2003
130	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 11/2005
83	Infections 06/2024 - 09/2002
71	Neoplasm Metastasis (Metastasis) 02/2024 - 11/2004
58	Lung Neoplasms (Lung Cancer) 01/2024 - 04/2007
39	Carcinogenesis 02/2024 - 06/2007
37	Adenocarcinoma of Lung 01/2024 - 05/2015
35	Inflammation (Inflammations) 02/2024 - 06/2006
31	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 11/2009
30	Adenocarcinoma 03/2024 - 02/2004
28	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 02/2003
25	Fibrosis (Cirrhosis) 04/2024 - 01/2007
25	Pain (Aches) 01/2024 - 07/2006
22	Alzheimer Disease (Alzheimer's Disease) 04/2024 - 01/2007
22	Stomach Neoplasms (Stomach Cancer) 10/2023 - 06/2005
21	COVID-19 07/2023 - 01/2020
20	Wounds and Injuries (Trauma) 04/2024 - 01/2013
20	Disease Progression 02/2024 - 08/2003
19	Cognitive Dysfunction 04/2024 - 03/2014
18	Breast Neoplasms (Breast Cancer) 12/2023 - 09/2009
18	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 12/2003
17	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 06/2011
17	Carcinoma (Carcinomatosis) 05/2023 - 02/2004
16	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 06/2015
16	Schizophrenia (Dementia Praecox) 03/2024 - 11/2009
16	Renal Cell Carcinoma (Grawitz Tumor) 07/2023 - 09/2006
15	Hemorrhage 04/2024 - 08/2008
15	Virus Diseases (Viral Diseases) 01/2024 - 11/2013
14	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 08/2003
13	Hypertension (High Blood Pressure) 02/2024 - 01/2013
13	Rectal Neoplasms (Rectal Cancer) 01/2023 - 11/2010
12	Hypoxia (Hypoxemia) 02/2024 - 12/2012
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 08/2015
12	Liver Neoplasms (Liver Cancer) 11/2023 - 11/2012
12	Lymphatic Metastasis 02/2023 - 12/2003
11	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023 - 11/2009
11	Stroke (Strokes) 02/2023 - 05/2012
11	Melanoma (Melanoma, Malignant) 11/2022 - 12/2007
11	Esophageal Neoplasms (Esophageal Cancer) 01/2021 - 03/2013
10	Fatigue 01/2024 - 02/2016
10	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 05/2015
10	Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational) 08/2023 - 05/2018
10	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2007
10	Ischemic Stroke 01/2023 - 10/2013
10	Necrosis 12/2022 - 01/2006
9	Type 2 Diabetes Mellitus (MODY) 04/2024 - 02/2013

Drug/Important Bio-Agent (IBA)

109	Proteins (Proteins, Gene)FDA Link 04/2024 - 09/2002
61	Biomarkers (Surrogate Marker)IBA 03/2024 - 08/2008
38	MicroRNAs (MicroRNA)IBA 02/2023 - 01/2011
36	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 06/2005
35	ErbB Receptors (EGF Receptor)IBA 01/2023 - 12/2008
34	Messenger RNA (mRNA)IBA 01/2024 - 10/2003
32	CytokinesIBA 10/2023 - 01/2007
30	Tyrosine Kinase InhibitorsIBA 01/2023 - 06/2009
29	RNA (Ribonucleic Acid)IBA 09/2023 - 09/2006
26	Long Noncoding RNAIBA 01/2023 - 07/2016
25	VaccinesIBA 02/2023 - 12/2008
24	Immune Checkpoint InhibitorsIBA 05/2024 - 01/2018
23	Therapeutic UsesIBA 04/2024 - 06/2002
21	Phosphotransferases (Kinase)IBA 04/2024 - 06/2009
21	Antiviral Agents (Antivirals)IBA 01/2024 - 08/2003
20	Interleukin-6 (Interleukin 6)IBA 01/2024 - 08/2003
19	AntigensIBA 09/2023 - 12/2003
19	LigandsIBA 01/2023 - 11/2006
18	PlatinumIBA 03/2024 - 06/2008
17	EnzymesIBA 12/2023 - 06/2006
17	AntibodiesIBA 01/2023 - 08/2003
16	Amyloid (Amyloid Fibrils)IBA 04/2024 - 09/2011
16	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2024 - 11/2004
16	InterferonsIBA 03/2024 - 12/2012
16	asenapine FDA Link 06/2015 - 11/2009
14	Peptides (Polypeptides)IBA 01/2024 - 01/2006
13	Olanzapine (Zyprexa)FDA Link 07/2022 - 12/2009
13	Small Interfering RNA (siRNA)IBA 09/2020 - 12/2007
12	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023 - 10/2011
12	CateninsIBA 01/2023 - 10/2016
12	apatinibIBA 01/2023 - 09/2017
11	Cisplatin (Platino)FDA LinkGeneric 11/2022 - 03/2014
10	Circular RNAIBA 01/2024 - 01/2018
10	Caspase 3 (Caspase-3)IBA 12/2022 - 10/2011
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 11/2005
9	hydroxide ionIBA 04/2024 - 03/2010
9	SteroidsIBA 03/2024 - 11/2017
9	SolutionsIBA 03/2024 - 08/2008
9	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 05/2004
9	CrizotinibIBA 02/2024 - 10/2015
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024 - 08/2003
9	AntioxidantsIBA 01/2024 - 01/2013
9	B7-H1 AntigenIBA 11/2023 - 01/2018

Therapy/Procedure

167	Therapeutics 04/2024 - 10/2003
110	Drug Therapy (Chemotherapy) 02/2024 - 12/2006
43	Immunotherapy 03/2024 - 03/2006
37	Radiotherapy 11/2023 - 11/2004
13	Aftercare (After-Treatment) 04/2024 - 10/2013
13	Lasers (Laser) 04/2024 - 06/2011
13	Neoadjuvant Therapy 12/2023 - 11/2010
11	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2024 - 10/2011
10	Length of Stay 04/2024 - 03/2013
10	Transplantation 04/2024 - 01/2012
9	Lymph Node Excision (Lymph Node Dissection) 09/2023 - 09/2013